SCHEMBL1704863

SCHEMBL1704863

OCc1cc(COC2CCCCO2)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
CREBBP Q92793 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ICAM1 P05362 1/20 0.39
SELE P16581 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
EP300 Q09472 1/20 0.38
DHFR P00374 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
HTR2C P28335 4/20 0.35
SLC6A4 P31645 4/20 0.35
P2RX3 P56373 3/20 0.35
IDO1 P14902 1/20 0.34
AXL P30530 1/20 0.33
MERTK Q12866 1/20 0.33
TACR1 P25103 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1705151 0.87 L3MBTL1 (0.38) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL23647767 0.85 ICAM1 (0.39) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL26978833 0.83 NPC1 (0.43) ICAM1SELENPC1RAB9A
SCHEMBL23647809 0.82 ICAM1 (0.39) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL1704760 0.82 L3MBTL1 (0.40) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL92906 0.82 DRD4 (0.47) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL1732484 0.81 ALDH1A1 (0.46) L3MBTL1MEN1KMT2AICAM1SELE
SCHEMBL1732627 0.79 KDM4C (0.41) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL1704820 0.79 ICAM1 (0.39) L3MBTL1CREBBPMEN1KMT2AICAM1
SCHEMBL22165283 0.77 ICAM1 (0.39) L3MBTL1CREBBPMEN1KMT2AICAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2357178-B1 Process for the production of L-2-[18F]fluor-phenylalanine and 6-[18F]fluor-L-meta-tyrosine and their alpha-alkylated derivatives from a precursor. FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2014-05-07 EP disclosed
US-8273793-B2 Method for producing precursors for L-2- [18F] fluorophenylalanine and 6- [18F] fluoro-L—meta-tyrosine and the α-methylated derivatives thereof, precursor, and method for producing L-2- [18F] fluorophenylalanine and 6- [18F] fluoro-L-meta-tyrosine and the α-methylated derivatives from the precursor FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2012-09-25 US disclosed
US-8273793-B2 Method for producing precursors for L-2- [18F] fluorophenylalanine and 6- [18F] fluoro-L—meta-tyrosine and the α-methylated derivatives thereof, precursor, and method for producing L-2- [18F] fluorophenylalanine and 6- [18F] fluoro-L-meta-tyrosine and the α-methylated derivatives from the precursor FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2012-09-25 US disclosed
EP-2222644-B9 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE ALPHA -METHYLATED DERIVATIVES THEREOF AND THE PRECURSORS FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2012-04-18 EP disclosed
EP-2222644-B9 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE ALPHA -METHYLATED DERIVATIVES THEREOF AND THE PRECURSORS FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2012-04-18 EP disclosed
EP-2357178-A1 Process for the production of L-2-[18F]fluor-phenylalanine and 6-[18F]fluor-L-meta-tyrosine and their alpha-alkylated derivatives from a precursor Forschungszentrum Jülich GmbH (DE) 2011-08-17 EP disclosed
EP-2357178-A1 Process for the production of L-2-[18F]fluor-phenylalanine and 6-[18F]fluor-L-meta-tyrosine and their alpha-alkylated derivatives from a precursor Forschungszentrum Jülich GmbH (DE) 2011-08-17 EP disclosed
EP-2222644-B1 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE ALPHA -METHYLATED DERIVATIVES THEREOF AND THE PRECURSORS FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2011-08-03 EP disclosed
EP-2222644-B1 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE ALPHA -METHYLATED DERIVATIVES THEREOF AND THE PRECURSORS FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2011-08-03 EP disclosed
US-20100256389-A1 METHOD FOR PRODUCING PRECURSORS FOR L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L--META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L-META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES FROM THE PRECURSOR FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2010-10-07 US disclosed
US-20100256389-A1 METHOD FOR PRODUCING PRECURSORS FOR L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L--META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L-META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES FROM THE PRECURSOR FORSCHUNGSZENTRUM JUELICH GMBH (DE) 2010-10-07 US disclosed
EP-2222644-A2 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE ALPHA -METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L-META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES FROM THE PRECURSOR Forschungszentrum Jülich GmbH (DE) 2010-09-01 EP disclosed
WO-2009071050-A2 METHOD FOR PRODUCING PRECURSORS FOR L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L--META-TYROSINE AND THE α-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2-[18F]FLUOROPHENYLALANINE AND 6-[18F]FLUORO-L-META-TYROSINE AND THE α-METHYLATED DERIVATIVES FROM THE PRECURSOR Forschungszentrum Jülich GmbH (DE) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256389-A1 METHOD FOR PRODUCING PRECURSORS FOR L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L--META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES THEREOF, PRECURSOR, AND METHOD FOR PRODUCING L-2- [18F] FLUOROPHENYLALANINE AND 6- [18F] FLUORO-L-META-TYROSINE AND THE ALPHA-METHYLATED DERIVATIVES FROM THE PRECURSOR TH, TYR, COMT L3MBTL1 218/4885CREBBP 4259/4885MEN1 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.